1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

China-Malaysia Partnership to Establish State-Of-The-Art Regenerative Medicine and Health Complex

23 Sep 2024
Admin
News Article

China-Malaysia Partnership to Establish State-Of-The-Art Regenerative Medicine and Health Complex

Overview

European Wellness and Jilin Hanxing Group forge strategic partnership to advance global wellness initiatives In a landmark move set to reshape the landscape of global wellness and regenerative medicine, European Wellness Biomedical Group and Jilin Hanxing Group have signed a pivotal strategic cooperation agreement.

Dignitories Present for the Agreement

Dr Mike Chan (left in the image), Scientist, Founder and Chairman of European Wellness Biomedical Group, and Fang Tie Ji (right in the image), Chairman of Jilin Hanxing Group, a multi-billion dollar conglomerate from Donggang City, Liaoning Province, China, formalised the agreement.

The Agreement

The agreement outlines plan for a joint venture project to establish a state-of-the-art Regenerative Medicine and Health Complex in Sanya, Hainan, China.
This ambitious project is envisioned as a trinity of 'medicine, beauty, and health therapy', positioning itself at the forefront of the global wellness industry.
The partnership will facilitate knowledge exchange and collaborative research, potentially accelerating breakthroughs in regenerative medicine and anti-aging therapies.

Aim for New Complex

The new complex aims to attract health-conscious individuals from around the world, positioning Sanya as a premier destination for medical wellness tourism.
In the interim, Sabah (in Malaysia) will see an influx of high-value medical wellness tourists from China.

European Wellness will gain enhanced access to the vast Chinese market, while Jilin Hanxing Group will benefit from European Wellness' global expertise and reputation.